Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Crit Rev Oncol Hematol. 2008 Jul 2;67(3):268–272. doi: 10.1016/j.critrevonc.2008.04.006

Table 3.

Characteristics of Chemotherapy [Median- 3 cycles (range: 1–24 cycles)]

Single agent N=65 (% of patients)
  Carboplatin 13 (20)
  Cisplatin 8 (12)
  Gemcitabine 8 (12)
  Docetaxel 6 ( 9)
  Other 30 (46)
Multiple agents N=68
  Carboplatin/paclitaxel 26 (38)
  CHOP/R-CHOP* 10 (14)
  Carboplatin/etoposide 7 (10)
  Other 25 (37)
*

Cyclophosphamide, vincristine, adriamycin, predinsone, Rituxmab